Zagazig University Digital Repository
Home
Thesis & Publications
All Contents
Publications
Thesis
Graduation Projects
Research Area
Research Area Reports
Search by Research Area
Universities Thesis
ACADEMIC Links
ACADEMIC RESEARCH
Zagazig University Authors
Africa Research Statistics
Google Scholar
Research Gate
Researcher ID
CrossRef
Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
Faculty
Medicine
Year:
2020
Type of Publication:
ZU Hosted
Pages:
Authors:
Amro Shaban Hanafy Elsayed
Staff Zu Site
Abstract In Staff Site
Journal:
world journal of gastroenterology Baishideng Publishing Group
Volume:
Keywords :
Challenges , COVID-19 drug treatment , patients with
Abstract:
The global incidence of coronavirus disease 2019 (COVID-19) continues to increase despite health care efforts. The disease is caused by coronavirus 2 with high transmission and mortality rates. Little is known about the management of COVID-19 in advanced liver disease. The aim of work was to propose a plan for management of this drastic disease in case of this specific population with review of medications that could be suitable for advanced liver disease. All the guidelines and medications available for treatment of COVID-19 were reviewed with selection of the less toxic medications that could be used in advanced liver disease. Drugs suitable to manage COVID-19 in patients with liver disease might include remdesivir intravenously, nitazoxanide + sofosbuvir, ivermectin, tocilizumab, convalescent plasma, and low molecular weight heparin in certain situations. Advanced liver disease is associated with portal hypertension and splenomegaly with reduction of blood elements and immune dysfunction and impaired T cell function. Thus, when confronted by cytokine storm as an immune response to COVID-19, there may be an increase in the mortality rate of these patients. Through this review, a plan to treat COVID-19 in this special group of patients with advanced cirrhosis is proposed.
Author Related Publications
Amro Shaban Hanafy Elsayed, "Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a one year experience.", springer, 2016
More
Amro Shaban Hanafy Elsayed, "efficacy of argon plasma coagulation in the management of portal hypertensive gastropathy", thieme publishers, 2016
More
Amro Shaban Hanafy Elsayed, "Association of thrombogenic genes polymorphisms with hepatocellular carcinoma in HCV Egyptian patients. Gene 2016;580: 37–40", Elsevier, 2016
More
Amro Shaban Hanafy Elsayed, "Association of thrombogenic gene polymorphisms with hepatocellular carcinoma in HCV Egyptian patients", Elsiever, 2016
More
Amro Shaban Hanafy Elsayed, "Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease", HINDAWI, 2017
More
Department Related Publications
Ahmed Adel Hassan Muhamad, "انتاج منشطات الخلايا المساعدة فى متلقى زراعة الكلى والمؤثرات الموجهة والتأثير على نتيجة الزرع", لايوجد, 1900
More
Ahmed Abdelshafy Hilal, "اثر البذل العلاجي علي حجم الدم الشرياني بمرضي التبف الكبدي المعانين للاستسقاء البريوني", لايوجد, 1900
More
Hamed Abdelaziz Deraz, "تقييم نتائج العلاج الطبى للاورام الغدة النخامية " البرولاكتيوما" بواسطة التصوير بالرنين المغناطيسى", لايوجد, 1900
More
Hamed Abdelaziz Deraz, "عامل نمو الخلايا المبطنة للاوعية الدموية وتكوين اوعية دموية جديدة بشبكية مرض السكرى", لايوجد, 1900
More
Hamed Abdelaziz Deraz, "مقارنة عقار الكابتوبريل بعقار النيفيديبين كعلاج لارتفاع ضغط الدم فى وجود او عدم وجود انسداد شعبى هوائق مزمن", لايوجد, 1900
More
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
شراقوة
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف